Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00344630 · ClinicalTrials.gov registry record · NA

TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

A NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
2,500
Enrollment target
1
Study location

NCT00344630: Completed NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.

NCT00344630 is a NA study of Coronary Artery Disease that has completed, run by Boston Scientific Corporation. The registered enrollment target is 2,500 participants, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00344630, a NA study of Coronary Artery Disease, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target
1
Study location

Study Summary

To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine performance of the two stents in pre-specified subgroup populations and examine regional and national patterns in outcomes.

Conditions Studied

Coronary Artery Disease

Interventions

  • DEVICE TAXUS Stent and Cypher Stent

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2006-05
Est. Completion 2006-06
Phase NA
Boston Scientific Corporation

280 total trials

What the finished NCT00344630 record still lists

NCT00344630 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% higher).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which TAXUS Stent and Cypher Stent is the first listed.

NCT00344630 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00344630 about?

NCT00344630 is a clinical study titled "TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?". To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine perf...

What is the current status of trial NCT00344630?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2006-05. Estimated completion is 2006-06.

What conditions does trial NCT00344630 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00344630?

The interventions under investigation include: TAXUS Stent and Cypher Stent (DEVICE).

Who is sponsoring clinical trial NCT00344630?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00344630 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00344630's enrollment target sits among peer trials

2,500 22nd of 219 higher than 197 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00344630, the US trial registry maintained by the National Library of Medicine. NCT00344630 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.